Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
August 1, 1981
[Myelocytic leukemia and its classification]
T Maekawa, S Umegae
Nihon Jinzo Gakkai Shi
|
March 1, 1978
[Experimental membranous glomerulonephritis induced in rats by the injection of pronase-digested homologous renal tubular epithelial antigen. II. Sequential ultrastructural observation of the glomerular lesion by electron microscopy (author's transl)]
S Umegae, T Fukasawa, T Naruse
Alimentary Pharmacology & Therapeutics
|
March 17, 2004
Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse
T Yamamoto, S Umegae, T Kitagawa, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
January 25, 2020
Reply to Lee and Brown
T Yamamoto, M Nakahigashi, T Shimoyama, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
November 30, 2019
Does preoperative enteral nutrition reduce the incidence of surgical complications in patients with Crohn's disease? A case-matched study
T Yamamoto, M Nakahigashi, T Shimoyama, et al.
Alimentary Pharmacology & Therapeutics
|
May 4, 2016
Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply
T Yamamoto, T Shimoyama, S Umegae, et al.
Alimentary Pharmacology & Therapeutics
|
April 5, 2016
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply
T Yamamoto, T Shimoyama, S Umegae, et al.
Alimentary Pharmacology & Therapeutics
|
January 15, 2016
Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study
T Yamamoto, T Shimoyama, S Umegae, et al.
Alimentary Pharmacology & Therapeutics
|
January 19, 2007
Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study
T Yamamoto, M Nakahigashi, S Umegae, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1978
Experimental membranous glomerulonephritis in rats: correlation of ultrastructural changes with the serum level of autologous antibody against tubular antigen
T Naruse, T Fukasawa, S Umegae, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
August 1, 1981
[Myelocytic leukemia and its classification]
T Maekawa, S Umegae
Nihon Jinzo Gakkai Shi
|
March 1, 1978
[Experimental membranous glomerulonephritis induced in rats by the injection of pronase-digested homologous renal tubular epithelial antigen. II. Sequential ultrastructural observation of the glomerular lesion by electron microscopy (author's transl)]
S Umegae, T Fukasawa, T Naruse
Alimentary Pharmacology & Therapeutics
|
March 17, 2004
Mucosal cytokine production during remission after resection for Crohn's disease and its relationship to future relapse
T Yamamoto, S Umegae, T Kitagawa, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
January 25, 2020
Reply to Lee and Brown
T Yamamoto, M Nakahigashi, T Shimoyama, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland
|
November 30, 2019
Does preoperative enteral nutrition reduce the incidence of surgical complications in patients with Crohn's disease? A case-matched study
T Yamamoto, M Nakahigashi, T Shimoyama, et al.
Alimentary Pharmacology & Therapeutics
|
May 4, 2016
Letter: which patient profile for tacrolimus in ulcerative colitis? Authors' reply
T Yamamoto, T Shimoyama, S Umegae, et al.
Alimentary Pharmacology & Therapeutics
|
April 5, 2016
Editorial: tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis--authors' reply
T Yamamoto, T Shimoyama, S Umegae, et al.
Alimentary Pharmacology & Therapeutics
|
January 15, 2016
Tacrolimus vs. anti-tumour necrosis factor agents for moderately to severely active ulcerative colitis: a retrospective observational study
T Yamamoto, T Shimoyama, S Umegae, et al.
Alimentary Pharmacology & Therapeutics
|
January 19, 2007
Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn's disease: A prospective, non-randomized, parallel, controlled study
T Yamamoto, M Nakahigashi, S Umegae, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
August 1, 1978
Experimental membranous glomerulonephritis in rats: correlation of ultrastructural changes with the serum level of autologous antibody against tubular antigen
T Naruse, T Fukasawa, S Umegae, et al.
Page
of 2